Marcus Freytag
Dr. med.
Marcus Freytag
  • Oberärztlicher Leiter MVZ-MKG
  • Medical Specialist in Oral and Maxillofacial Surgery
  • Plastic Surgeries
Working area

Location

Main Building O10
Languages
German (Mother tongue)
English
French

Areas of expertise

Publications

Zurück
  • 2014
Vor

Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer
Laban S, Atanackovic D, Luetkens T, Knecht R, Busch C, Freytag M, Spagnoli G, Ritter G, Hoffmann T, Knuth A, Sauter G, Wilczak W, Blessmann M, Borgmann K, Münscher A, Clauditz T
INT J CANCER. 2014.

Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo
Wei J, Freytag M, Schober Y, Nockher W, Mautner V, Friedrich R, Manley P, Kluwe L, Kurtz A
PLOS ONE. 2014;9(10):e107760.

Letzte Aktualisierung aus dem FIS: 15.10.2019 - 05:17 Uhr